We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

43 hedge funds and large institutions have $34.4M invested in Spruce Biosciences in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less funds holding

Funds holding: 50 → 43 (-7)

56% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 18

57% less capital invested

Capital invested by funds: $79M → $34.4M (-$44.6M)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
43
Holders Change
-7
Holders Change %
-14%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
18
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$271K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$220K
3
State Street
State Street
Massachusetts
+$195K
4
Renaissance Technologies
Renaissance Technologies
New York
+$178K
5
BCM
Bridgeway Capital Management
Texas
+$90.4K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$542K
2
Goldman Sachs
Goldman Sachs
New York
-$467K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$318K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$267K
5
LGM
Logos Global Management
California
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$9.07M – – –
OFM
2
Omega Fund Management
Massachusetts
$4.34M – – –
RVM
3
RiverVest Venture Management
Missouri
$4.32M – – –
Citadel Advisors
4
Citadel Advisors
Florida
$3.46M -$13K -70 -0.3%
RSCM
5
Rock Springs Capital Management
Maryland
$3.26M – – –
ACM
6
Aisling Capital Management
New York
$2.42M – – –
LGM
7
Logos Global Management
California
$2.01M -$248K -1,334 -9%
SCV
8
Sands Capital Ventures
Virginia
$1.58M – – –
BlackRock
9
BlackRock
New York
$1.06M +$271K +1,457 +26%
BCM
10
Bridgeway Capital Management
Texas
$495K +$90.4K +486 +17%
State Street
11
State Street
Massachusetts
$413K +$195K +1,046 +62%
Vanguard Group
12
Vanguard Group
Pennsylvania
$309K -$542K -2,912 -59%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$255K -$38.3K -206 -11%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$234K +$220K +1,181 +317%
JP Morgan Chase
15
JP Morgan Chase
New York
$227K -$12.3K -66 -4%
Renaissance Technologies
16
Renaissance Technologies
New York
$225K +$178K +958 +180%
Northern Trust
17
Northern Trust
Illinois
$143K -$10.8K -58 -6%
Goldman Sachs
18
Goldman Sachs
New York
$85K -$467K -2,508 -82%
MAM
19
Marquette Asset Management
Minnesota
$82K – – –
PPA
20
Parametric Portfolio Associates
Washington
$55K -$92.3K -496 -58%
Charles Schwab
21
Charles Schwab
California
$38K – – –
State Board of Administration of Florida Retirement System
22
State Board of Administration of Florida Retirement System
Florida
$35K – – –
CSS
23
Cubist Systematic Strategies
Connecticut
$27K -$67.9K -365 -67%
Barclays
24
Barclays
United Kingdom
$25K +$31.4K +169 New
Nuveen
25
Nuveen
North Carolina
$24K – – –
1
2 3

SPRB Hedge Fund Activity: Q1 2022 in Review

43 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q1 2022, worth a combined $34.4M — down 57% from $79M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SPRB and 4 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 8 added.

The largest buyer was BlackRock, adding an estimated $271K. The largest seller was Vanguard Group, cutting an estimated $542K.

  • 43 institutional investors held Spruce Biosciences (SPRB) as of Q1 2022, down from 50 in Q4 2021.
  • Funds reported $34.4M of Spruce Biosciences stock for Q1 2022, down 57% quarter-over-quarter.
  • 4 funds opened new Spruce Biosciences positions in Q1 2022 and 11 closed out, a net change of -7 holders.
  • The largest Spruce Biosciences buyer in Q1 2022 was BlackRock, an estimated $271K added.
  • The largest Spruce Biosciences seller in Q1 2022 was Vanguard Group, an estimated $542K sold.

Based on aggregated 13F filings for Q1 2022.